Global Biologics Market Research Report: Forecast (2025-2030)

Biologics Market - By Therapeutic Application (Oncology, Infectious Disease, Autoimmune Disease, Diabetes, Cardiovascular Diseases, Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalm... ... Disorders, Ophthalmic Disorders, etc.)), By Drug Class (Recombinant Proteins, [Hormones, Cytokines], Monoclonal Antibodies, Blood & Blood Components, Cellular & Gene Therapy, Vaccines, Others), By Source (Microbes, Humans, Others (Rodents, Plants, etc.)), Others Read more

  • Healthcare
  • Apr 2024
  • 197
  • PDF, Excel, PPT

Market Definition

Biologics are medications that are either sourced from living organisms or composed of elements from living organisms and are commonly found in the form of genetically engineered proteins. These pharmaceuticals play a crucial role in addressing chronic ailments such as cancer, neurology issues, cardiovascular disorders, etc.

Market Insights & Analysis: Global Biologics Market (2025-30):

The Global Biologics Market size was valued at USD 412 Billion in 2024 and is projected to reach USD 612 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 8.25% during the forecast period, i.e., 2025-2030. The surging expenditures in healthcare, a hike in the sedentary lifestyles of individuals, and the rising number of chronic disease patients are some of the highlighting aspects promoting the industry growth. Other factors driving the demand for biologics across the global scale include enhanced usage of monoclonal antibodies for disease treatment, innovation & advancement in the healthcare & biotechnology sectors, and to cure diseases, including anemia, rheumatoid arthritis, osteoporosis, Alzheimer's, etc. Also, diseases like cancer and autoimmune disorders, which pose significant healthcare challenges, underscore the importance of targeted therapeutic interventions, and hence, have been driving the need for biologics over the historical years.

Report Coverage Details
  Historical Years   2020-23
  Base Years
  2024
  Forecast Years
  2025-30
  Market Value in 2024   USD 412 Billion
  Market Value in 2030   USD 612 Billion
  CAGR (2025-30)   8.25%
  Leading Region   North America
  Top Key Players Bristol-Myers Squibb, Pfizer, Sanofi, Janssen Biotech, Inc., Bayer AG, Merck & Co., Amgen Inc., Abbott GmbH, Novartis, AstraZeneca Plc, GlaxoSmithKline Biologicals, Moderna, Inc., Ferring Pharmaceuticals Inc., Aimmune Therapeutics, Inc., F. Hoffman La Roche, and Others
  Key Report Highlights
  • Market Dimensions & Projections
  • Pricing Evaluation,
  • Recent Strategic Moves by Companies,
  • Primary Stakeholders,
  • Analysis of Import and Export Trends,
  • Competitive Landscape Assessment,
  • Emerging Opportunities,
  • Market Trends and Indicators

 

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Moreover, the incessant surge in the old age population is notably augmenting the demand for biologics such as erythropoietin (EPO), denosumab, teriparatide, etc. Furthermore, fastened regulatory approvals from the governments in different countries were also contributing to the growth of the Biologics market. For instance:

  • In 2023, the FDA sanctioned 35 fresh biologics as part of their documented progress toward decreased regulation and expansion of gene & cell therapy offerings. During H1-22, The Center for Drug Evaluation and Research approved an additional 10 innovative biologics medicines compared to last year's figures.

Hence, with improved regulatory approvals, the launch of new biologics in the market has accelerated. Moreover, as Biologics offers tailored solutions targeting specific cells or molecules responsible for diseases, it not only enhances treatment efficacy but also mitigates adverse effects significantly, thus its adoption is anticipated to boost in the coming years as well.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. Global Biologics Market Clinical Trial Analysis
  5. Global Biologics Guidelines by Government Organizations
    1. World Health Organisation (WHO)
    2. European Medicines Agency (EMA)
    3. Food and Drug Administration (FDA)
  6. Global Biologics Market Patent Analysis
  7. Global Biologics Market Trends & Developments
  8. Global Biologics Market Dynamics
    1. Growth Drivers
    2. Challenges
  9. Global Biologics Market Hotspot & Opportunities
  10. Global Biologics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Therapeutic Application
        1. Oncology- Market Size & Forecast 2020-2030, (USD Million)
        2. Infectious Disease- Market Size & Forecast 2020-2030, (USD Million)
        3. Autoimmune Disease- Market Size & Forecast 2020-2030, (USD Million)
        4. Diabetes- Market Size & Forecast 2020-2030, (USD Million)
        5. Cardiovascular Diseases- Market Size & Forecast 2020-2030, (USD Million)
        6. Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2020-2030, (USD Million)
      2. By Drug Class
        1. Recombinant Proteins- Market Size & Forecast 2020-2030, (USD Million)
          1. Hormones- Market Size & Forecast 2020-2030, (USD Million)
          2. Cytokines- Market Size & Forecast 2020-2030, (USD Million)
        2. Monoclonal Antibodies- Market Size & Forecast 2020-2030, (USD Million)
        3. Blood & Blood Components- Market Size & Forecast 2020-2030, (USD Million)
        4. Cellular & Gene Therapy- Market Size & Forecast 2020-2030, (USD Million)
        5. Vaccines- Market Size & Forecast 2020-2030, (USD Million)
        6. Others- Market Size & Forecast 2020-2030, (USD Million)
      3. By Source
        1. Microbes- Market Size & Forecast 2020-2030, (USD Million)
        2. Humans- Market Size & Forecast 2020-2030, (USD Million)
        3. Others (Rodents, Plants, etc.)- Market Size & Forecast 2020-2030, (USD Million)
      4. By Region
        1. North America
        2. South America
        3. Europe
        4. The Middle East & Africa
        5. Asia-Pacific
      5. By Company
        1. Competition Characteristics
        2. Revenue Shares & Analysis
  11. North America Biologics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
      2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
      3. By Source- Market Size & Forecast 2020-2030, (USD Million)
      4. By Country Market Size & Forecast 2020-2030, (USD Million)
        1. The US
        2. Canada
        3. Mexico
    3. The United States Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    4. Canada Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    5. Mexico Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
  12. South America Biologics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
      2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
      3. By Source- Market Size & Forecast 2020-2030, (USD Million)
      4. By Country- Market Size & Forecast 2020-2030, (USD Million)
        1. Brazil
        2. Rest of South America
    3. Brazil Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
  13. Europe Biologics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
      2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
      3. By Source- Market Size & Forecast 2020-2030, (USD Million)
      4. By Country- Market Size & Forecast 2020-2030, (USD Million)
        1. Germany
        2. The UK
        3. France
        4. Italy
        5. Spain
        6. Rest of Europe
    3. Germany Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    4. The UK Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    5. France Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    6. Italy Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    7. Spain Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
  14. Middle East & Africa Biologics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
      2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
      3. By Source- Market Size & Forecast 2020-2030, (USD Million)
      4. By Country- Market Size & Forecast 2020-2030, (USD Million)
        1. The UAE
        2. Saudi Arabia
        3. South Africa
        4. Rest of the Middle East & Africa
    3. The UAE Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    4. Saudi Arabia Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    5. South Africa Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
  15. Asia-Pacific Biologics Market Outlook, 2020-2030F
    1. Market Size & Analysis
      1. By Revenues (USD Million)
    2. Market Share & Analysis
      1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
      2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
      3. By Source- Market Size & Forecast 2020-2030, (USD Million)
      4. By Country- Market Size & Forecast 2020-2030, (USD Million)
        1. China
        2. India
        3. Japan
        4. South Korea
        5. Australia
        6. Rest of Asia-Pacific
    3. China Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    4. India Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    5. Japan Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    6. South Korea Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
    7. Australia Biologics Market Outlook, 2020-2030F
      1. Market Size & Analysis
        1. By Revenues (USD Million)
      2. Market Share & Analysis
        1. By Therapeutic Application- Market Size & Forecast 2020-2030, (USD Million)
        2. By Drug Class- Market Size & Forecast 2020-2030, (USD Million)
  16. Global Biologics Market Key Strategic Imperatives for Success & Growth
  17. Competition Outlook
    1. Company Profiles
      1. Bristol-Myers Squibb
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Pfizer
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Sanofi
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Janssen Biotech, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Bayer AG
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Merck & Co.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Amgen Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Abbott GmbH
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Novartis
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      10. AstraZeneca Plc
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      11. GlaxoSmithKline Biologicals
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      12. Moderna, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      13. Ferring Pharmaceuticals Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      14. Aimmune Therapeutics, Inc.
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      15. F. Hoffman La Roche
        1. Business Description
        2. Product Portfolio
        3. Strategic Alliances or Partnerships
        4. Recent Developments
        5. Financial Details
        6. Others
      16. Others
  18. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .